# Focal Cerebral Arteriopathy Steroid Trial

> **NCT06040255** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **University of California, San Francisco** · enrollment: 80 (estimated)

## Conditions studied

- Pediatric Stroke
- Arteriopathy
- Arterial Ischemic Stroke

## Interventions

- **DRUG:** methylprednisolone, prednisolone, prednisone

## Key facts

- **NCT ID:** NCT06040255
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-10-01
- **Primary completion:** 2029-07-31
- **Final completion:** 2030-01-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-01-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06040255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06040255, "Focal Cerebral Arteriopathy Steroid Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06040255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*